Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.

A similar trend towards greater trabecular volume was also observed in combination treated mice compared to those treated with bortezomib alone, although this did not reach statistical significance (Figure 8C ).

also in 111,027 other papers